Bank Pictet & Cie (Europe)’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $99M | Sell |
393,597
-10,507
| -3% | -$2.26M | 1.93% | 12 |
|
|
2026
Q1 | $87.9M | Sell |
404,104
-16,899
| -4% | -$3.75M | 1.87% | 14 |
|
|
2025
Q4 | $96.2M | Buy |
421,003
+33,881
| +9% | +$7.72M | 1.92% | 12 |
|
|
2025
Q3 | $89.6M | Buy |
387,122
+112,421
| +41% | +$22.9M | 1.79% | 11 |
|
|
2025
Q2 | $51M | Sell |
274,701
-9,740
| -3% | -$1.81M | 1.09% | 27 |
|
|
2025
Q1 | $59.6M | Buy |
284,441
+78,930
| +38% | +$15.3M | 1.42% | 20 |
|
|
2024
Q4 | $36.5M | Sell |
205,511
-1,060
| -0.5% | -$195K | 0.8% | 37 |
|
|
2024
Q3 | $40.8M | Buy |
206,571
+9,990
| +5% | +$1.86M | 0.96% | 28 |
|
|
2024
Q2 | $33.7M | Buy |
196,581
+10,476
| +6% | +$1.74M | 0.82% | 33 |
|
|
2024
Q1 | $33.9M | Buy |
186,105
+46,143
| +33% | +$7.95M | 0.88% | 34 |
|
|
2023
Q4 | $21.7M | Buy |
139,962
+4,400
| +3% | +$641K | 0.64% | 44 |
|
|
2023
Q3 | $20.2M | Buy |
135,562
+47,019
| +53% | +$6.9M | 0.7% | 41 |
|
|
2023
Q2 | $11.9M | Buy |
88,543
+1,919
| +2% | +$281K | 0.41% | 56 |
|
|
2023
Q1 | $13.8M | Sell |
86,624
-924
| -1% | -$141K | 0.57% | 47 |
|
|
2022
Q4 | $14.1M | Buy |
87,548
+74,738
| +583% | +$11.5M | 0.69% | 40 |
|
|
2022
Q3 | $1.72M | Buy |
12,810
+9,660
| +307% | +$1.39M | 0.08% | 90 |
|
|
2022
Q2 | $482K | Sell |
3,150
-80
| -2% | -$12.2K | 0.02% | 117 |
|
|
2022
Q1 | $524K | Hold |
3,230
| – | – | 0.02% | 121 |
|
|
2021
Q4 | $437K | Hold |
3,230
| – | – | 0.01% | 137 |
|
|
2021
Q3 | $348K | Hold |
3,230
| – | – | 0.01% | 144 |
|
|
2021
Q2 | $364K | Hold |
3,230
| – | – | 0.01% | 151 |
|
|
2021
Q1 | $350K | Buy |
+3,230
| New | +$345K | 0.01% | 143 |
|
|
2019
Q1 | – | Sell |
-3,911
| Closed | -$361K | – | 151 |
|
|
2018
Q4 | $361K | Sell |
3,911
-1,490
| -28% | -$131K | 0.07% | 103 |
|
|
2018
Q3 | $511K | Buy |
5,401
+195
| +4% | +$18.5K | 0.07% | 122 |
|
|
2018
Q2 | $482K | Buy |
5,206
+195
| +4% | +$19K | 0.07% | 119 |
|
|
2018
Q1 | $474K | Sell |
5,011
-5
| -0.1% | -$549 | 0.08% | 117 |
|
|
2017
Q4 | $485K | Sell |
5,016
-10,438
| -68% | -$984K | 0.07% | 123 |
|
|
2017
Q3 | $1.37M | Hold |
15,454
| – | – | 0.2% | 73 |
|
|
2017
Q2 | $1.12M | Buy |
15,454
+1,152
| +8% | +$77.4K | 0.16% | 89 |
|
|
2017
Q1 | $932K | Sell |
14,302
-1,242
| -8% | -$78.1K | 0.13% | 86 |
|
|
2016
Q4 | $973K | Buy |
15,544
+586
| +4% | +$35.8K | 0.16% | 79 |
|
|
2016
Q3 | $943K | Sell |
14,958
-550
| -4% | -$35.6K | 0.17% | 78 |
|
|
2016
Q2 | $960K | Hold |
15,508
| – | – | 0.2% | 70 |
|
|
2016
Q1 | $886K | Buy |
15,508
+4,218
| +37% | +$235K | 0.18% | 68 |
|
|
2015
Q4 | $669K | Sell |
11,290
-300
| -3% | -$17.3K | 0.13% | 90 |
|
|
2015
Q3 | $631K | Buy |
11,590
+2,500
| +28% | +$163K | 0.15% | 100 |
|
|
2015
Q2 | $611K | Buy |
9,090
+1,700
| +23% | +$111K | 0.61% | 52 |
|
|
2015
Q1 | $433K | Sell |
7,390
-250
| -3% | -$15.1K | 0.1% | 132 |
|
|
2014
Q4 | $500K | Hold |
7,640
| – | – | 0.13% | 120 |
|
|
2014
Q3 | $441K | Buy |
7,640
+550
| +8% | +$30.5K | 0.12% | 115 |
|
|
2014
Q2 | $400K | Hold |
7,090
| – | – | 0.12% | 107 |
|
|
2014
Q1 | $364K | Hold |
7,090
| – | – | 0.13% | 104 |
|
|
2013
Q4 | $374K | Buy |
+7,090
| New | +$348K | 0.15% | 102 |
|
Other funds holding ABBV
N
Bank Pictet & Cie (Europe)'s ABBV Position: Q2 2026 in Review
Bank Pictet & Cie (Europe) reduced its AbbVie (ABBV) stake by 2.6% in Q2 2026, selling an estimated $2.26M and leaving 393,597 shares worth $99M. The position accounts for 1.93% of the portfolio, ranked #12.
Bank Pictet & Cie (Europe) first reported a position in ABBV in Q4 2013 and has held it in 43 quarters since. 3,029 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Bank Pictet & Cie (Europe) held 393,597 shares of AbbVie worth $99M as of Q2 2026.
- Bank Pictet & Cie (Europe) sold 10,507 AbbVie shares in Q2 2026, an estimated $2.26M.
- AbbVie made up 1.93% of Bank Pictet & Cie (Europe)'s portfolio in Q2 2026, its #12 holding.
- Bank Pictet & Cie (Europe) first reported a position in AbbVie in Q4 2013 and has held it in 43 quarters since.
- 3,029 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Bank Pictet & Cie (Europe)'s 13F filing for Q2 2026, filed 24 Jul 2026.